Imara Inc. (IMRA): Price and Financial Metrics
IMRA Price/Volume Stats
| Current price | $48.16 | 52-week high | $60.73 |
| Prev. close | $49.79 | 52-week low | $42.23 |
| Day low | $48.00 | Volume | 5,500 |
| Day high | $50.05 | Avg. volume | 2,653 |
| 50-day MA | N/A | Dividend yield | N/A |
| 200-day MA | N/A | Market Cap | 3.37M |
IMRA Stock Price Chart Interactive Chart >
Imara Inc. (IMRA) Company Bio
Imara, Inc. engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. Its product candidate, IMR-687 is a highly selective and small molecule inhibitor of PDE9. The company was founded by James G. McArthur in 2016 and is headquartered in Cambridge, MA.
IMRA Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
IMRA Price Returns
| 1-mo | 4.25% |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 4,670.21% |
| 5-year | 21.48% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | 0.00% |
| 2022 | 81.77% |
| 2021 | -89.80% |
| 2020 | N/A |